We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Cutting-Edge Transbronchial Aspiration Needle to Revolutionize Minimally Invasive Diagnostic Techniques

By HospiMedica International staff writers
Posted on 11 Sep 2023

An innovative transbronchial aspiration (TBNA) needle is redefining the norms for accuracy, user-friendliness, and patient comfort, offering healthcare providers an unprecedented tool for obtaining top-quality tissue samples crucial for the reliable diagnosis and staging of lung cancer. More...

Broncus Medical (San Jose, CA, USA) has unveiled its game-changing BioStar TBNA Needle designed to transform minimally invasive diagnostic procedures, thereby enhancing patient care and clinical outcomes. This cutting-edge needle seamlessly integrates with endobronchial ultrasound bronchoscopy (EBUS) procedures and is compatible with both traditional TBNA (cTBNA) and EBUS-enabled TBNA (EBUS-TBNA) diagnostic methods.

The BioStar TBNA Needle stands out for its superior, ultra-slim design, which minimizes tissue damage, enhances reach, reduces the force needed for puncturing, and improves patient comfort during the sampling process. Equipped with an improved needle design and exceptional ultrasound echogenicity, the device allows clinicians to navigate complex anatomical structures with pinpoint accuracy. Its ergonomically designed handle ensures optimum maneuverability, enabling seamless control and precise needle placement during various medical procedures.

Featuring a Beak-shaped needle tip, the BioStar TBNA Needle enhances sample gathering capabilities and ensures optimal specimen extraction for reliable pathological examination. The needle is available with two tip configurations—standard Slant and Beak-shaped tips. Designed with an easy-to-use interface and straightforward setup, the BioStar TBNA Needle streamlines the procedural routine, which is invaluable in high-paced clinical environments. Available in 21G, 22G, and 25G needle sizes, the 21G BioStar EBUS needle features thin walls, allowing for better access to hard-to-reach nodes while collecting samples like a 19G needle. The BioStar TBNA Needle is now accessible to healthcare professionals in Europe and other global locations, except for the USA, who are looking to enhance their diagnostic capabilities.

"Our commitment to advancing patient care and diagnostic accuracy has driven us to develop the BioStar TBNA Needle – a revolutionary tool that empowers medical professionals to make confident, informed decisions," said Christian Rumpf, PhD, Sr. Director Sales & Marketing Europe.

Related Links:
Broncus Medical 


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Radiology System
Riviera SPV AT
Newborn Hearing Screener
ALGO 7i
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.